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Abstract
The European Centre for Disease Prevention and Control (ECDC) started to work on information gathering for early detection of pub-
lic health threats in June 2005. Since then, based on a framework including events and data-based surveillance, EDCD has been learning
by doing. The internal tools and procedures for epidemic intelligence (EI) were developed while screening signals. Information including
relevant epidemiological data, media news detected and actions taken are recorded in a speciﬁc event information system (Threat
Tracking Tool). We describe the main elements, process and outputs of EI activities at ECDC. We also describe the main results
regarding travel-related diseases. Efforts are needed to better identify and gather information about travellers coming to the EU with
imported diseases with a potential for further spread inside our territory.
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Introduction
On 2 January 2009, an Arab-language newspaper reported
that pneumonic plague had killed 40 terrorists in Algeria (http://
www.dailymail.co.uk/news/worldnews/article-1121842/Al-
Qaeda-hit-Black-Death-fear-medieval-plague-kills-40-terro-
rists-training-camp.html). In July 2008, a Dutch tourist returning
from Uganda was diagnosed with Marburg haemorrhagic
fever and subsequently died (http://ecdc.europa.eu/en/Health_
Topics/ebola_marburg_fevers/Article_20080805.aspx accessed
24 January 2009). In December 2008, a traveller presenting
with haemorrhagic fever was reported to have ﬂown
from South Africa to Brazil [ProMED-mail. VIRAL HEMOR-
RHAGIC FEVER – BRAZIL (RIO de JANEIRO) ex SOUTH
AFRICA: REQUEST FOR INFORMATION. ProMED-mail
2008; 2 December: 20081202.3792, http://www.promed
mail.org accessed 23 March 2009]. These are some examples
of the potential risks associated with infectious diseases that
European citizens expect health authorities to prevent.
Epidemic intelligence (EI) encompasses all activities related
to the early identiﬁcation of potential health hazards, their
veriﬁcation, assessment and investigation in order to provide
appropriate options for public health control measures.
EI integrates both an indicator-based and an event-based
component in a single surveillance system. Indicator-based or
classic surveillance is based on the routine (i.e. weekly,
monthly) reporting of cases of disease (i.e. notiﬁable disease
surveillance systems, sentinel surveillance, laboratory-based
surveillance), and it is mostly healthcare-facility based. The
pitfalls of this system are the rapid detection of outbreaks or
the detection of emerging health threats. The event-based com-
ponent refers to unstructured data gathered from sources of
intelligence of any nature that help in detecting events that
happen in populations without access to formal healthcare.
Another difference is that events are reported immediately
after detection. This is a great advantage in detecting new
and rare events and enables rapid risk assessment [1–3].
This article focuses on a description of the event-based com-
ponent of EI activities carried out at the European Centre for
Disease Prevention and Control (ECDC), with special emphasis
on the detection of threats associated with international travel.
According to the World Tourism Organization, nearly
900 million tourists engaged in international travel in 2007, with
a rate of increase of 5% per annum (http://www.unwto.org/
media/news/en/press_det.php?id=1665 accessed 12 January
2009). People, human and animal food, as well as wild and
domestic animals or their products travel across the globe in
just a few hours, providing increasing opportunity for germs to
travel as well.
Journal Compilation ª2009 European Society of Clinical Microbiology and Infectious Diseases
No claim to original US government works
OVERVIEW 10.1111/j.1469-0691.2009.02875.x
The Elements of Epidemic Intelligence
EI activities at the ECDC are organized around a team of four
epidemiologists operating in the ECDC emergency operation
centre which is equipped with state-of-the-art communica-
tions technology. Standard operating procedures ensure
optimal efﬁciency in the detection of threats, which are
tracked through information systems supported by a network
of dedicated epidemiologists in the EU member states. This
network comprises epidemiologists involved in disease
surveillance (e.g. European surveillance network for vaccine-
preventable diseases, http://www.euvac.net/, or European
Working Group for Legionella Infections, http://www.
ewgli.org/) as well as travel medicine specialists (European
Travel Medicine Network, http://www.istm.org/eurotravnet/
main.html) and microbiologists (European Network for
Diagnostics of Imported Viral Diseases, http://enivd.de/VHFDI-
SEASES/fs_vhfdiseases.htm).
A team of communicable diseases experts assesses
detected emerging threats, evaluates their public health
impact in the EU and liases with the European Commission
to support public health response by the EU member states.
The Process
Daily, EI ofﬁcers review information collected from various
ofﬁcial and unofﬁcial sources (Table 1). Conﬁdential sources,
such as the Early Warning and Response System (EWRS) [4],
allowing secure exchange among EU member states, the
International Health Regulations notiﬁcations system and
the Global Outbreak Alert and Response Network (http://
www.who.int/csr/outbreaknetwork/fr/index.html) represent
an important source of conﬁdential information. The increas-
ing use of the internet by EU citizens and organizations, pub-
lic and private, is making the management of open sources of
information a critical factor in detecting public health events
and monitoring their impact [5–7].
Filtering of the information collected through these
sources is critical, as the increasing use of informal sources
of information has resulted in a huge increase in available
information, including irrelevant information. The initial ﬁlter-
ing of data concerning an event relies on the judgment of
the EI ofﬁcers, guided by internal criteria for EU relevance
and public health impact. The initial review of an event
should result in either discarding the event as not relevant
or including it in the list of events to be validated. Validation
is done by obtaining conﬁrmation from ofﬁcial sources or by
cross-matching independent reports. Sometimes, these
events are veriﬁed at source, before the ECDC starts moni-
toring them. Then, veriﬁed events become signals that
require an assessment of their relevance at European level
and of their public health impact. The severity of the disease
(morbidity, case fatality rate), mode of transmission and
capacity to spread, difﬁculty of diagnosis (awareness among
doctors and nurses, lack of diagnostic tests, etc) and control,
the anticipated media and political attention, or the possibi-
lity of an intentional release (bioterrorism) are among the
criteria used to assess signals. These assessments focus on
the European implication of the threat, in terms of spread
and coordination of the implementation of control measures,
in accordance with the principle of subsidiarity that mandates
the EU national authorities’ response to threats [8]. Assess-
ments are carried out by experts of the Centre’s units and
programmes during a meeting that takes place daily, the
Round Table (RT) meeting.
Once a signal is conﬁrmed as a potential public health
threat at the EU level, the threat is registered in the ECDC
Threat Tracking Tool, allowing monitoring and the logging of
actions implemented for its control. This ensures the
accountability and traceability of ECDC activities in the
detection and assessment of, and response to, emerging
threats.
The assessment of a signal can lead to the creation of an
internal response team, involving external experts when
required. Upon request from Member States or the WHO,
the ECDC will identify a team of appropriate experts to be
dispatched in support of outbreak control operations.
Outputs
As a result of its EI activities, the ECDC produces a weekly
bulletin, the Communicable Disease Threat Report (CDTR),
every Friday, summarizing the current status of threats moni-
tored by the ECDC. The CDTR is distributed to a restricted
list of National Health Authorities, the European Commis-
sion and other relevant stakeholders, after authorization by
National Health authorities. Daily, a bulletin reﬂecting discus-
sions during the RT meeting complements the CDTR by
providing the latest threats and developments.
Ad hoc facts sheets and threat assessments are prepared
and updated when needed. These outputs are usually made
public through the ECDC website and distributed to the
National Health authorities and relevant stakeholders
through the EWRS. Yearly, an annual threat report is com-
piled and included in the ECDC epidemiological annual
report. This report is available on the ECDC website.
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Results
Between the establishment of the ECDC in June 2005 and
December 2008, 639 threats have been monitored and 6222
items of information regarding these threats have been
recorded. The distribution of monitored threats according
to disease group is shown in Table 2. It is important to men-
tion that inﬂuenza-related threats are grouped in only three
threat groups in the database (Threat-Tracking Tool), seaso-
nal ﬂu in the EU, and avian inﬂuenza A (H5N1) worldwide
and within the WHO EURO region. The geographical distri-
bution of the threats monitored is presented in Table 3.
More than two-thirds of the threats monitored by the
ECDC involve EU or European Free Trade Association-Eur-
opean Economic Area (EFTA-EEA) Member States. Other
geographical regions commonly involved include Asia, espe-
cially south-east Asia, and Africa.
On average, the delay between a source reporting an
event and the ECDC initiating monitoring is 1 day. Veriﬁca-
tion is carried out within 2 days of signaling the threat. The
initial assessment of the event is completed, on average,
within 3 days of threat detection.
Among emerging threats originating in the EU, 83% are
primarily detected though conﬁdential sources of informa-
tion, mainly the EWRS. However, 56% of emerging threats
originating outside of the EU are primarily detected through
non-conﬁdential sources (Table 4).
Selected Travel-Related Diseases and
Events Monitored by the ECDC
In the summer of 2007, in Emilia-Romagna, a single traveller
returning from India developed symptoms of Chikungunya
TABLE 2. Distribution of monitored threats according to
disease groups (June 2005–December 2008)
Disease group n
Diseases of environmental or zoonotic origin 239
Food- and water-borne diseases 184
Vaccine preventable diseases and diseases due to invasive bacteria 60
Tuberculosis 33
Inﬂuenza 19
Anti-microbial resistance and healthcare associated infections 7
Hepatitis, HIV, STI, blood-borne infections 6
Not applicable 91
Total 639
Source: ECDC Threat Tracking Tool.
TABLE 1. Selected sources routi-
nely monitored for communicable
disease threat detection
Source denomination Internet address
GOARN http://sharepoint.who.int/sites/GOARN/default.aspx
Promed: Program for Monitoring Emerging Diseases http://www.promedmail.org
MediSys: Medical Information System http://medusa.jrc.it/medisys/homeedition/all/home.html.
Healthmap: Global Disease Alert Map http://www.healthmap.org
Biocaster: Global Health Monitor http://biocaster.nii.ac.jp/
AlertNet (Reuters) http://www.alertnet.org
GPHIN: Global Public Health Intelligence Network https://www.gphin.net
WHO Avian Flu web page http://www.who.int/csr/disease/avian_inﬂuenza/en/
WHO CSR disease outbreak news http://www.who.int/csr/don/en/
WHO EURO: outbreaks http://www.euro.who.int/surveillance/outbreaks/
20021015_1
OIE alert messages: World Organisation for
Animal Health
http://www.oie.int/eng/info/en_urgences.htm
EWRS messages restricted access website
Hong Kong Avian Flu monitoring http://www.info.gov.hk/info/ﬂu/eng/global.htm
CIDRAP (Univ. of Minnesota): Centre for
Infectious Diseases Research and Policy
http://www.cidrap.umn.edu/index.html
WHO SEARO (South East Asia) website http://w3.whosea.org/
WHO cholera website http://www.who.int/topics/cholera/en/
WHO Polioeradication program website http://www.polioeradication.org/pressreleases.asp
CDC MMWR http://www.cdc.gov/mmwr/
WHO WER http://www.who.int/wer/2007/en/
FAO Avian Flu web page (and periodic reports) http://www.fao.org/ag/againfo/subjects/en/health/diseases-
cards/avian_update.html
GOARN, Global Outbreak Alert & Response Network.
TABLE 3. Distribution of threats by region of origin (June
2005–December 2008)
Region Total %
European Union* 549 68.0
Africa 79 9.8
Americas 53 6.6
Asia 102 12.6
Australia and Oceania 6 0.7
Russia 18 2.2
Total 807 100.0
*Including countries of the European Economic Area (EEA) that are participating
in the European Free Trade Association (EFTA): Iceland, Norway and Liechten-
stein.
Source: ECDC Threat Tracking Tool.
Note: The numbers total is more than the total number of threats as a single
threat can affect more than one geographical region.
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fever and initiated an epidemic involving approximately 250
cases. Although not currently providing advice on health
issues for travellers, the ECDC is monitoring very closely
threats that may result in secondary cases occurring in the
EU, such as dengue fever, Chikungunya or viral haemorrhagic
fevers.
Dengue
In 2007, outbreaks in Brazil, Bolivia, Colombia, Costa Rica,
Honduras, Mexico, Paraguay and Venezuela highlighted the
explosive nature of dengue epidemics and prompted the
Pan-American Health Organization (PAHO) to issue alerts
across Latin America. Until 2003, only DEN-1 and DEN-2
virus circulated in the region, leaving a high proportion of
the population susceptible to the now circulating DEN-3 ser-
otype virus (see PAHO Highlight on Dengue: http://www.pa-
ho.org/english/ad/dpc/cd/dengue.htm accessed 24 January
2009).
Since 1 January 2008, Brazil has experienced an epidemic
of dengue fever, with >730 000 clinical cases and 212 deaths
reported up to week 35, compared with almost 560 000
cases of dengue in 2007 and 158 deaths. The majority of
cases originated from Mato Grosso do Sul, a state that bor-
ders Paraguay and Bolivia (see: http://ecdc.europa.eu/en/
Health_Topics/Dengue_fever/080308_update.aspx).
The number of cases reported in Thailand is also increas-
ing, with a total of 37 128 in 2008, compared with <15 000
cases in 2007 (Department of Disease Control, Ministry of
Public Health, Thailand, http://203.157.15.4/surdata/disea-
se.php?ds=66 accessed 24 January 2009).
Dengue fever does not naturally occur in the continental EU
nowadays, even though large outbreaks have occurred in the
past, such as in 1927 in Greece [9]. However, travellers are
frequently affected while returning from south-east Asia and
the Indian subcontinent, but also, increasingly, from South
and Central America and the Caribbean. Between 2002 and
2007, 876 cases of imported dengue fever were reported
to EuroTropNet (http://www.tropnet.net/reports_friends/pdf_
reports_friends/may08_dengue07_friends.pdf accessed 24 Jan-
uary 2009). The recent autochthonous transmission of
Chikungunya virus in Italy and the presence of Aedes albopictus
in Europe highlight the need for continuous awareness of
dengue virus infection.
The ECDC updates weekly the situation of dengue
fever worldwide. Pro-MED (39%), public reports on the
web (22%) and the Global Public Health Intelligence Net-
work (12%) are the main sources of information for this
update.
Chikungunya
At the end of 2005 and in early 2006, Chikungunya fever
resulted in a large outbreak affecting the French Island of La
Re´union, a European Overseas Territory. Subsequently, it
spread to different states of India (Tamil Nadu, Karnataka,
Kerala and Gujarat), Sri Lanka and Malaysia. This spread in
the northern hemisphere resulted in an exposure of EU
travellers during summer months, being the active period for
vectors in the EU such as A. albopictus. As a result, the
ECDC conducted, in March 2006, an assessment of the risk
of establishment of Chikungunya transmission and initiated
preparedness activities (ECDC Consultation on Chikungunya
risk assessment for Europe, http://ecdc.europa.eu/docu
ments/pdf/Final_chik_meeting_report.pdf accessed 30 March
2006).
In the summer of 2007, the ﬁrst local transmission of Chi-
kungunya virus on the European continent was reported in
Italy. Between July and September, 247 cases were reported
from four provinces in the Emilia-Romagna region, 217 of
which were laboratory conﬁrmed. This outbreak led to a
joint ECDC/WHO visit to the affected area to assess the
risk on a European level (ECDC, Mission report: Chikungu-
nya in Italy. Joint ECDC/WHO visit for a European Risk
Assessment, 17–21 September 2007, http://ecdc.europa.eu/
documents/pdf/071020_CHK_report.pdf accessed 24 January
2009).
In 2008, Chikungunya virus transmission was reported
from Indonesia, where recurrent epidemics have occurred
since the 1970s. Recently – affected areas include Central,
West Java and Sumatra. In Singapore, local transmission was
reported for the ﬁrst time with a cluster of 13 cases.
The ECDC continues to closely monitor the situation of
Chikungunya worldwide. More than 200 updates have been
prepared since the establishment of the ECDC in March
2005. Pro-MED (47%) and public reports on the web (22%)
are the main sources of information.
TABLE 4. Distribution of initial source of information
according to region and conﬁdentiality levels (June 2005–
December 2008)
Conﬁdential
Non-
conﬁdential Total
n % n % n
EU 446 83% 93 17% 539
Non-EU 110 44% 140 56% 250
Total 556 70% 233 30% 789
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Viral Haemorrhagic Fevers
In contrast with dengue fever and Chikungunya fever, which
can start autochthonous transmission through mosquito vec-
tors present in the EU, viral haemorrhagic fever caused by
Lassa, Ebola or Marburg viruses cannot result in extended
transmission once imported into the EU, but may generate a
few secondary cases, especially in hospital care settings if not
promptly diagnosed, and in relation to breach of universal
precautions. Since June 2005, two separate events involved
the travel of a patient affected by Lassa fever to the EU [10]
(Case of Lassa Fever in Specialist Unit in London. 23 January
2009. United Kingdom Health Protection Agency National
Press Releases: http://www.hpa.org.uk/webw/HPAweb&Page
&HPAwebNewsroom/Page/1153846674338?p=1153846674338
accessed 2 February 2009), which justiﬁed the tracing of con-
tacts. No further transmission was identiﬁed. Recently, one
EU visitor to Uganda developed Marburg haemorrhagic fever
and died. Contacts were traced and no further transmission
was identiﬁed.
In October 2008, a new Arena virus was identiﬁed in
South Africa in a patient evacuated from Zambia. Three sub-
sequent cases resulted from nosocomial transmission. Three
of the four cases were fatal (ECDC Threat Assessment:
Unknown Disease Identiﬁed in South Africa, 3 deaths,
ex-Zambia. 10 October 2008. http://ecdc.europa.eu/en/ﬁles/
pdf/Health_topics/20081010_unknown_disease_Zambia-Final.
pdf). Recently, an outbreak of Ebola Reston virus affected
pigs in the Philippines, triggering an investigation coordinated
by the WHO to assess the risk for humans (Ebola-Reston in
pigs in the Philippines 2008: WHO Situation Summary,
Updated 19 December 2008. http://www.wpro.who.int/health_
topics/ebola_reston accessed on 17 March 2009).
The ECDC closely monitors outbreaks of viral haemor-
rhagic fever worldwide, to anticipate the public health impact
of such an introduction into the EU.
Tuberculosis
Tuberculosis (TB) is of great public health concern when
exposure to infectious cases occurs in a conﬁned environ-
ment such as in planes and ships. The ECDC has monitored
23 of those threats since May 2005 (16 in planes, four in
ships, one involving a bus, two involving international
schools). Assessment of the events in accordance with
WHO guidelines (Tuberculosis and air travel: guidelines for
prevention and control – 3rd ed. ‘‘WHO/HTM/TB/
2008.399’’, WHO 2008, http://www.who.int/tb/publications/
2008/WHO_HTM_TB_2008.399_eng.pdf) and coordination of
contact tracing when appropriate were the main actions
taken by the ECDC. Fig. 1 represents the trend of media
reports scanned in 2007 by MedISis related to TB and
signiﬁcant events that were monitored by the ECDC. Peaks
tend to occur immediately after events that can imply a pub-
lic health threat. The most signiﬁcant example was the event
involving an extensively drug resistant (XDR)-TB case in a
US citizen travelling from the USA to Europe, who visited
different countries and travelled back to the USA (US CDC
Investigation of U.S. Traveler with Extensively Drug Resistant
Tuberculosis (XDR TB). May 29, 2007. Available at: http://
www2a.cdc.gov/HAN/ArchiveSys/ViewMsgV.asp?AlertNum=
00262 accessed 24 January 2009).
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Conclusions
In a globalized world, travel-related public health risks are
increasingly important. The ECDC, as a new institution in
the EU, is mandated to monitor, detect, assess and ensure
appropriate responses to emerging threats. This can be
achieved only through a partnership of experts involved in
ensuring health security. In this context, the ECDC, since its
establishment, has been aiming at developing collaboration
with epidemiologists, microbiologists, and clinicians from the
various EU member states.
Efforts need to be made to better identify and gather
information about travellers coming to the EU with imported
diseases with a potential for further spread inside our terri-
tory. Open sources of information, those publically available
though the internet, are important sources to detect and
monitor events with possible impact on public health in the
EU, especially for events originating outside the EU borders.
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